The healthcare needs of pregnant adolescents will continue to be ignored in low-and middle-income countries (LMIC) unless there are major changes to healthcare delivery and frameworks, according to a new study by UCL and Murdoch Children’s Research Institute (MCRI) researchers.
Twice-Yearly Injection Yields Zero HIV Infections for High-Risk Women in Trial
The long-acting injectable antiretroviral drug lenacapavir (Sunlenca) was highly effective in preventing HIV infection in cisgender women in high-risk countries, according to an interim analysis
July 25, 2024